Lilly to sell obesity drugs directly on Hims & Hers site: Eli Lilly said on Friday it struck a deal to allow Hims & Hers Health to sell obesity drugs Zepbound ...
reuters.com/legal/litigation/lilly-sell-obesity-drugs-directly-hims-hers-site-2026-11-06/
Paid articlePaywall OpinionHims & Hers Health: Don't Nitpick Quarterly Results: Hims & Hers Health maintains robust growth prospects despite a minor Q3'26 revenue miss ...
seekingalpha.com/article/4965997-hims-and-hers-health-dont-nitpick-quarterly-results
Paid articlePaywall Midday Need to Know: CPI tops estimates, Treasury yields jump & more: October CPI beats forecasts at 0.4% vs. 0.3%, lifting Treasury yields; Hims & Hers Health ...
seekingalpha.com/news/4669969-midday-need-to-know-cpi-tops-estimates-treasury-yields-jump-more
Paid articlePaywall Hims & Hers Health slides 14% after earnings miss, guidance cut: Hims & Hers shares fall 14% after Q3 revenue of $890.3 million and EPS of -$0 ...
seekingalpha.com/news/4669870-hims-and-hers-health-slides-14-percent-after-earnings-miss-guidance-cut
Stocks making the biggest moves premarket: Sanmina, Hims & Hers, Securitize & more — Live updates
cnbc.com/2026/11/10/stock-market-movers-live-updates.html
Paid articlePaywall Hims & Hers Stock Extends Losses After Earnings Stumble: Analysts expect subscriber numbers to rise for the telehealth provider in the third quarter.
barrons.com/articles/hims-hers-earnings-stock-price-7869b1b3
Hims & Hers Short Interest Climbs to 23% Ahead of Earnings: Can the Stock Break Out? - Hims & Hers Health…
benzinga.com/markets/equities/26/11/63020607/hims-hers-short-interest-climbs-to-23-ahead-of-earnings-can-the-stock-break-out
Hims & Hers Health rises as HHS moves ahead with plan for compounding peptides: Hims & Hers stock jumps as HHS reviews policy letting compounding pharmacies make ...
seekingalpha.com/news/4653660-hims-and-hers-health-rises-hhs-moves-ahead-plan-compounding-peptides
Robinhood stock tokens fuelled a US$440 million memecoin frenzy: Low Ze Sheng has spent the past two years trading memecoins, chasing the jokes that send tokens ...
financialpost.com/fp-finance/cryptocurrency/robinhood-stock-tokens-fuelled-memecoin-frenzy
Fraudulent Weight Loss Drugs: FDA Warns Against Mislabeled GLP-1 Medications - Hims & Hers Health (NYSE:HIMS)
benzinga.com/news/fda/26/09/61570997/fraudulent-weight-loss-drugs-fda-warns-against-mislabeled-glp-1-medications
Barron's Aug 26
Paid articlePaywall How GLP-1 Sales Could Play Out for Hims & Hers: Hims & Hers Health is shifting its core weight-loss business from compounded GLP-1 drug sales to branded versions ...
barrons.com/articles/hims-hers-stock-glp-1-obesity-drugs-8c2b9569
Hims & Hers CEO is pushing back on FTC lawsuit over health data sharing: Andrew Dudum told CNBC the agency wanted "more of a headline than a real ...
qz.com/hims-hers-ceo-ftc-lawsuit-health-data-pushback-081826
Hims & Hers Topples As Deeper-Than-Expected Losses Outweigh Quarterly Beat: Hims stock fell late Monday after second-quarter losses came in bigger than expected ...
investors.com/news/technology/hims-stock-hims-hers-health-earnings-q2-2026/
As Hims prepares for peptides launch, Wall Street cautious on prospects this year
reuters.com/legal/litigation/hims-prepares-peptides-launch-wall-street-cautious-prospects-this-year-2026-08-12/
Hims & Hers shares slide as costly weight-loss push squeezes margins: Hims & Hers Health's shares fell over 2% in morning trading on Tuesday ...
reuters.com/business/healthcare-pharmaceuticals/hims-hers-shares-slide-costly-weight-loss-push-squeezes-margins-2026-08-11/
Paid articlePaywall Stocks making the biggest moves premarket: Riot Platforms, Hims & Hers Health, Intel & more
cnbc.com/2026/08/11/stocks-making-the-biggest-moves-premarket-riot-hims-intc.html
Hims & Hers: Great sales, poor margins - | Stock price plummets: Hims & Hers exceeds Q2 revenue forecast with USD 753 million, but lowers margin forecast for ...
deraktionaer.de/artikel/pharma-biotech/hims-hers-umsatz-hui-marge-pfui-aktie-sackt-ab-20406456.html
Will they beat quarterly earnings today?
What prediction markets price right now:
> 𝗚𝗲𝘁𝘁𝘆 𝗜𝗺𝗮𝗴𝗲𝘀 (𝗚𝗘𝗧𝗬) 𝟮𝟯%
> 𝗛𝗶𝗺𝘀 & 𝗛𝗲𝗿𝘀 𝗛𝗲𝗮𝗹𝘁𝗵 (𝗛𝗜𝗠𝗦) 𝟰𝟭%
> ... Show more
Hims and Hers shares fall 10% as FTC sues company over data, billing practices: The FTC sued Hims & Hers over alleged health data sharing with Meta and Snap ...
cnbc.com/2026/07/29/hims-and-hers-ftc-lawsuit-stock.html
1.15 Billion Deal: Hims & Hers Expands Radically: Hims & Hers Buys Itself into New Markets with Eucalyptus - | the billion-dollar deal fuels imaginations for the ...
wallstreet-online.de/nachricht/20954104-telemedizin-aktie-legt-zu-1-15-milliarden-deal-hims-hers-expandiert-radikal
Barron's May 27
Paid articlePaywall Hims Insider Makes First Stock Purchase Since 2021 Amid Weight-Loss Drug Pivot: Hims & Hers Health stock has slumped in 2026 as the telehealth provider moves ...
barrons.com/articles/hims-stock-insider-weight-loss-glp1-drug-0388a2a7
Hims offers Apotex’s generic semaglutide in Canada after Novo patent expiry: Hims & Hers Health said on Thursday it is now offering Canadians with type 2 ...
bnnbloomberg.ca/business/2026/05/21/hims-offers-apotexs-generic-semaglutide-in-canada-after-novo-patent-expiry/
Nebius, Hims & Hers, Cisco & Co. Which numbers will be exciting this week!: Investors need to know about these upcoming US quarterly figures (week 20).
wallstreet-online.de/nachricht/20853510-earnings-preview-nebius-hims-hers-cisco-co-zahlen-woche-spannend-werden
Moderna: Before the big outbreak: Moderna stock shows recovery after the coronavirus boom. New research on hantavirus vaccines raises optimistic expectations ...
deraktionaer.de/artikel/deraktionaermagazin/moderna-vor-dem-grossen-ausbruch--20400798.html
Hims & Hers plunges as branded weight-loss drug pivot hits results: Shares of Hims & Hers Health fell 11% on Tuesday after the telehealth company's pivot to ...
reuters.com/legal/litigation/hims-hers-plunges-after-weight-loss-pivot-hits-quarterly-results-2026-05-12/
Hims & Hers: Stock Takes a Plunge - | The Background: Hims & Hers Disappoints with Q1 Figures: Revenue Rises Only 4% to $608 Million, Margins Fall ...
deraktionaer.de/artikel/pharma-biotech/hims-hers-aktie-geht-baden-die-hintergruende-20400776.html
Hims & Hers Reverses Amid Doubts On Its Newest Obesity Plan: Hims stock reversed lower Thursday despite new efforts in weight loss that connect patients with Eli ...
investors.com/news/technology/hims-stock-eli-lilly-self-pay-pricing-lillydirect/
Hims stock price reacts strongly to crucial FDA review | HIMS: A pending FDA review of several peptides is giving investors a new growth story for Hims as the ...
thestreet.com/investing/stocks/hims-stock-price-reacts-strongly-to-crucial-fda-review
Barron's Apr 16
Paid articlePaywall Hims & Hers Health Stock Rallies on Regulatory Pivot. It’s Not About GLP-1s This Time.
barrons.com/articles/hims-hers-health-stock-peptides-kennedy-46f9b697
Hims & Hers Health: Almost 44 percent profit in just 10 trading days: Martin Päutz identifies lucrative rebound opportunities, such as the 43 ...
deraktionaer.de/artikel/aktien/hims-hers-health-knapp-44-prozent-gewinn-in-nur-10-handelstagen-20399419.html
RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves: Hims may have an chance to grow peptides business as a potential revenue driver ...
cnbc.com/2026/04/16/rfk-jr-peptides-hims-hers-glp-1.html
Paid articlePaywall Hims & Hers stock jumps as U.S. moves forward with plan to reassess popular peptides
marketwatch.com/story/hims-hers-stock-jumps-as-u-s-moves-forward-with-plan-to-reassess-popular-peptides-4815d489
Hims rises as FDA considers broader peptides access; analysts see long-term win: Shares of Hims & Hers Health rose more than 7% on Thursday as analysts said the ...
reuters.com/business/healthcare-pharmaceuticals/hims-rises-fda-considers-broader-peptides-access-analysts-see-long-term-win-2026-04-16/
Hims & Hers Analyst Cuts Price Target On Downside Risk - Hims & Hers Health (NYSE:HIMS)
benzinga.com/analyst-stock-ratings/price-target/26/04/51710488/hims-hers-health-analyst-cuts-price-target-on-downside-risk
OKLO's Isotope Push Could Support Long-Term Growth Opportunity: OKLO's isotope strategy aims to fix fragile global supply by converting nuclear waste into ...
qz.com/oklo-s-isotope-push-could-support-long-term-growth-opportunity
Barron's Apr 08
Paid articlePaywall New Derivative Income ETFs Aren’t Worth the Risks: There are now a host of funds that use options to generate income from an individual stock ...
barrons.com/articles/new-derivative-income-etfs-single-stock-599aba6e
Hims & Hers Expands Personalized Digital Healthcare Platform: HIMS builds a digital-first healthcare platform, integrating telehealth, AI and personalized ...
qz.com/hims-hers-expands-personalized-digital-healthcare-platform
Earnings Season Looms: Why It Matters: The period is undoubtedly hectic for market participants, with companies finally revealing what's transpired behind closed ...
qz.com/earnings-season-looms-why-it-matters
Novo Nordisk drops its Hims & Hers patent lawsuit as Wegovy and Ozempic head to the Hims platform
apnews.com/article/hims-hers-novo-nordisk-wegovy-ozempic-fda-d56b8ad0737be75674bc05ffe488b948
Erneuter Rückschlag für Novo Nordisk. Nachdem der Kurs gerade erst begonnen hatte, sich vom letzten Rückschlag zu erholen ... Show more
Novo Nordisk: As if that wasn't enough!: Novo Nordisk erhält FDA-Warnung und zeigt Schwäche gegenüber Eli Lilly im Adipositas-Markt.
deraktionaer.de/artikel/pharma-biotech/novo-nordisk-auch-das-noch-20396914.html
+49%: This stock shoots up after deal with Novo Nordisk!: Novo Nordisk surprisingly resumes its cooperation with Hims & Hers on Wegovy distribution ...
wallstreet-online.de/nachricht/20591050-ueberraschung-montag-49-aktie-schiesst-deal-novo-nordisk-oben
Stocks Recover as Oil Retreats From $119: Stock Market Today: How high the price of crude oil rises and how long it stays there are critical questions for market ...
kiplinger.com/investing/stocks/stocks-recover-as-oil-retreats-from-usd119-stock-market-today
Novo and Hims to sell obesity drugs together as feud ends, Bloomberg News reports
reuters.com/business/healthcare-pharmaceuticals/novo-hims-resolve-dispute-will-sell-obesity-drugs-together-bloomberg-news-2026-03-07/
Paid articlePaywall Novo and Hims End Feud, Will Sell Obesity Drugs Together
bloomberg.com/news/articles/2026-03-07/novo-and-hims-end-feud-will-sell-obesity-drugs-together
Why Novo Nordisk's Ireland expansion is key to fighting off Eli Lilly: Novo Nordisk is investing in a facility in Ireland as it expands its production capacities ...
cnbc.com/2026/03/02/novo-nordisk-stock-eli-lilly-wegovy-ireland-supply-news.html
Hims crashes after forecast - | Novo Nordisk remains the accelerant: Despite strong Q4 figures, the new outlook creates a hole in the story. High expenses ...
wallstreet-online.de/nachricht/20533851-marge-kollabiert-hims-stuerzt-prognose-novo-nordisk-bleibt-brandbeschleuniger
Paid articlePaywall Hims & Hers’ expansion plans — as well as its Super Bowl ad — have investors worried about profits
marketwatch.com/story/hims-hers-expansion-plans-as-well-as-its-super-bowl-ad-have-investors-worried-about-profits-1e60d262
Paid articlePaywall Hims & Hers is spending more than $1 billion in a push to expand globally: Stock bounces further off a 17-month low, after announcing deal to buy Australia-based ...
marketwatch.com/story/hims-hers-is-spending-more-than-1-billion-in-a-push-to-expand-globally-8a271a6e
Hims & Hers GLP-1 pill gambit backfires, accelerating crackdown on drug compounders
reuters.com/legal/litigation/hims-hers-glp-1-pill-gambit-backfires-accelerating-crackdown-drug-compounders-2026-02-19/
Hims & Hers Faces New Hurdle In Weight-Loss Brawl With Novo Nordisk: Hims stock landed in hot water this month after Novo Nordisk slammed the telehealth giant ...
investors.com/news/technology/hims-stock-compounded-semaglutide-oral-novo-nordisk-fda/
Share price in free fall: Novo Nordisk fights back against cheap Wegovy copy: Weight loss drugs are trending. The telemedicine provider Hims & Hers also wants to ...
n-tv.de/wirtschaft/Novo-Nordisk-wehrt-sich-gegen-Wegovy-Billigkopie-id30330285.html
Hims & Hers stock crashes after FDA announces plans to take 'decisive steps' against GLP-1 compounds.
Read more: Ihre Datenschutzeinstellungen
Weight-loss drugs to compete on biggest stage with Super Bowl ads: Ads during this year’s 60th Super Bowl, in which the Seattle Seahawks will take on the New ...
timeslive.co.za/news/world/2026-02-07-weight-loss-drugs-to-compete-on-biggest-stage-with-super-bowl-ads/
Novo Nordisk after the crash - | is that it?: Novo Nordisk share stabilizes despite forecast shock; JPMorgan and UBS maintain their valuations.
deraktionaer.de/artikel/pharma-biotech/novo-nordisk-nach-dem-crash-wars-das-20395039.html
BREAKING: Hims & Hers intensifies price pressure on Novo Nordisk - | Share price accelerates downward trend
deraktionaer.de/artikel/pharma-biotech/breaking-hims-hers-verschaerft-preisdruck-bei-novo-nordisk-aktie-beschleunigt-talfahrt-20394967.html
Paid articlePaywall Exclusive | Journalism-Powered Hedge Fund Hunterbrook Capital Finds Good News Can Be Profitable
wsj.com/finance/investing/hunterbrook-capital-journalism-hedge-fund-81adedf8
Paid articlePaywall Hims & Hers: The Market's Panic Is Irrational: Hims & Hers Health has sold off ~40% GLP-1 turbulence, but the core growth story remains intact ...
seekingalpha.com/article/4850985-hims-and-hers-the-markets-panic-is-irrational
The Three Moves Hims & Hers Made This Week To Bolster Its Weight-Loss Biz: Hims & Hers Health announced its expansion into Canada on Thursday ...
investors.com/news/technology/hims-stock-hims-hers-health-canada-livewell-yourbio/
Hims Says It's Negotiating A New Deal With Novo Nordisk; Shares Surge: Hims stock jumped Tuesday, despite a mixed third-quarter report, after the telehealth ...
investors.com/news/technology/hims-stock-hims-hers-health-novo-nordisk-wegovy/